<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Mastocytosis on Leukoformula</title><link>https://www.leukoformula.com/en/tags/mastocitoz/</link><description>Recent content in Mastocytosis on Leukoformula</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sat, 22 Jul 2023 19:37:48 +0300</lastBuildDate><atom:link href="https://www.leukoformula.com/en/tags/mastocitoz/feed.xml" rel="self" type="application/rss+xml"/><item><title>Systemic Mastocytosis: Clinical Case and Morphology</title><link>https://www.leukoformula.com/en/post/sistemnyy-mastocitoz-klinicheskiy-sluchay-i-12586/</link><pubDate>Sat, 22 Jul 2023 19:37:48 +0300</pubDate><guid>https://www.leukoformula.com/en/post/sistemnyy-mastocitoz-klinicheskiy-sluchay-i-12586/</guid><description>&lt;p>⚠Systemic mastocytosis. Clinical case.
✅A 42-year-old male with significant splenomegaly, hepatomegaly, and urticaria pigmentosa-like skin rash.
🔬Peripheral blood showed mild anemia: hemoglobin 113 g/L and leukopenia 3.11×10^9/L.
✅Bone marrow aspiration for IFT failed. Touch imprints from the trepanobiopsy were made: we see clusters of atypical mast cells.
❗Blood tryptase &amp;gt;200 µg/L (N = 0-11.4) – a marker of mast cell activation, a marker of mastocytosis.
✅Histology showed bone marrow infiltration by mast cells positive for CD117, CD25, CD2.&lt;/p></description></item></channel></rss>